We’d love your feedback!
We’re working on new tools and we want to make sure they’re truly useful to you.
Can you spare 30 seconds to answer 3 quick questions?
Your feedback directly shapes the future of Finviz.
Take the Survey
We’re working on new tools and we want to make sure they’re truly useful to you.
Can you spare 30 seconds to answer 3 quick questions?
Your feedback directly shapes the future of Finviz.
Take the Survey
|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | May 08 '25 | Sale | 43.81 | 10,000 | 438,101 | 8 | May 09 03:46 PM |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | May 07 '25 | Sale | 44.10 | 9,000 | 396,900 | 10,008 | May 08 05:16 PM |
| VZ | Malady Kyle | Officer | May 08 '25 | Proposed Sale | 43.81 | 10,000 | 438,102 | May 08 12:09 PM | |
| VZ | Malady Kyle | Officer | May 07 '25 | Proposed Sale | 44.10 | 9,000 | 396,901 | May 07 03:35 PM | |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Apr 30 '25 | Sale | 43.88 | 7,500 | 329,062 | 19,008 | May 01 04:11 PM |
| VZ | Malady Kyle | Officer | Apr 30 '25 | Proposed Sale | 43.88 | 7,500 | 329,062 | Apr 30 03:43 PM | |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Apr 24 '25 | Sale | 43.02 | 10,000 | 430,240 | 26,508 | Apr 25 04:22 PM |
| VZ | Malady Kyle | Officer | Apr 24 '25 | Proposed Sale | 43.02 | 10,000 | 430,240 | Apr 24 01:33 PM | |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Apr 23 '25 | Sale | 42.48 | 5,000 | 212,425 | 36,508 | Apr 24 01:31 PM |
| VZ | Malady Kyle | Officer | Apr 23 '25 | Proposed Sale | 42.48 | 5,000 | 212,425 | Apr 23 01:28 PM | |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Feb 04 '25 | Sale | 39.70 | 6,590 | 261,623 | 0 | Feb 06 11:16 AM |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Feb 03 '25 | Sale | 39.88 | 8,000 | 319,080 | 6,590 | Feb 05 10:25 AM |
| VZ | Malady Kyle | Officer | Feb 04 '25 | Proposed Sale | 39.70 | 6,590 | 261,624 | Feb 04 01:21 PM | |
| VZ | Malady Kyle | Officer | Feb 03 '25 | Proposed Sale | 39.88 | 8,000 | 319,080 | Feb 03 04:40 PM | |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Jan 29 '25 | Sale | 40.88 | 11,085 | 453,155 | 14,590 | Jan 31 11:18 AM |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Jan 28 '25 | Sale | 40.49 | 20,000 | 809,800 | 25,675 | Jan 30 10:17 AM |
| VZ | Malady Kyle | Officer | Jan 29 '25 | Proposed Sale | 40.88 | 11,085 | 453,155 | Jan 29 04:09 PM | |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Jan 27 '25 | Sale | 40.54 | 20,000 | 810,800 | 45,675 | Jan 29 11:44 AM |
| VZ | Malady Kyle | Officer | Jan 28 '25 | Proposed Sale | 40.49 | 20,000 | 809,803 | Jan 28 04:17 PM | |
| VZ | Malady Kyle | Officer | Jan 27 '25 | Proposed Sale | 40.72 | 10,000 | 407,223 | Jan 27 05:29 PM | |
| VZ | Malady Kyle | Officer | Jan 27 '25 | Proposed Sale | 40.35 | 10,000 | 403,493 | Jan 27 11:49 AM | |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Feb 22 '24 | Sale | 40.80 | 24,000 | 979,200 | 35,201 | Feb 26 10:47 AM |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Feb 15 '24 | Sale | 40.33 | 15,000 | 604,950 | 59,201 | Feb 20 07:37 AM |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Mar 15 '23 | Sale | 36.69 | 6,226 | 228,432 | 67,966 | Mar 17 07:55 AM |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Mar 13 '23 | Sale | 36.50 | 7,199 | 262,764 | 81,738 | Mar 15 11:13 AM |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Mar 14 '23 | Sale | 36.74 | 7,546 | 277,240 | 74,192 | Mar 15 11:13 AM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite